ERBB2 and breast carcinoma: Administration of 30 μM curcumin for 48 h induced mainly early apoptosis associated with little late apoptosis in MDA-MB-231 (ER-/PR-/HER2-/EGFR+) breast cancer cells, a model of triple negative breast cancer which is associated with poor prognosis.